Deep learning assisted differentiation of hepatocellular carcinoma from focal liver lesions: choice of four-phase and three-phase CT imaging protocol.

Journal: Abdominal radiology (New York)
Published Date:

Abstract

PURPOSE: To evaluate whether a three-phase dynamic contrast-enhanced CT protocol, when combined with a deep learning model, has similar accuracy in differentiating hepatocellular carcinoma (HCC) from other focal liver lesions (FLLs) compared with a four-phase protocol.

Authors

  • Wenqi Shi
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Sichi Kuang
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Sue Cao
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Bing Hu
    Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
  • Sidong Xie
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Simin Chen
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Yinan Chen
    12 Sigma Technologies, NO. 420 Fenglin Road, Xuhui District, Shanghai, China.
  • Dashan Gao
    12 Sigma Technologies, 11975 El Camino Real, Suite 102, San Diego, CA, 92130, USA.
  • Yunqiang Chen
    12 Sigma Technologies, 11975 El Camino Real, Suite 102, San Diego, CA, 92130, USA.
  • Yajing Zhu
    12 Sigma Technologies, NO. 420 Fenglin Road, Xuhui District, Shanghai, China.
  • Hanxi Zhang
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, China.
  • Hui Liu
    Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Meng Ye
    Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Claude B Sirlin
    Liver Imaging Group, Department of Radiology, University of California San Diego, La Jolla, CA, USA.
  • Jin Wang
    Cells Vision (Guangzhou) Medical Technology Inc., Guangzhou, China. Electronic address: wangjin@cellsvision.com.